AMETEK (AME) Q2 2026 earnings review
Record Top-Line Momentum Masks Underlying Margin Dilution
AMETEK delivered an exceptionally strong Q2 2026 on the surface, with sales surging 15% YoY to a record $2.04 billion and adjusted EPS growing 17% to $2.09. The primary growth engine is the Electromechanical Group (EMG), which expanded adjusted operating margins by a massive 290 basis points while growing sales 17%. Furthermore, the company reported a massive 28% growth in orders, proving sustained momentum. However, aggressive M&A activity is widening the gap between reported and adjusted numbers. While adjusted margins look stellar, GAAP operating margins actually contracted slightly due to acquisition dilution and integration costs. Still, confident in their order book, management raised full-year EPS guidance.
🐂 Bull Case
For the second consecutive quarter, orders grew at an exceptional rate (28% in Q2 vs 23% in Q1). This creates a massive backlog that provides high visibility and a protective buffer against macroeconomic volatility.
The Electromechanical Group is executing flawlessly. A 17% increase in sales translated to a 32% jump in adjusted operating profit, showcasing immense operating leverage and the end of any prior destocking headwinds.
🐻 Bear Case
Adjusted earnings benefited from a hefty $0.32 per share add-back for acquisition-related costs and integration. Underneath the non-GAAP adjustments, GAAP operating margin actually contracted YoY.
Despite 28% order growth, Q3 sales are guided to only 'high single digits' growth. This indicates that either backlog conversion is slowing due to supply chain constraints, or management is baking in severe macro conservatism.
⚖️ Verdict: 🟢
Bullish. AMETEK's ability to drive 28% order growth and 15% revenue growth at this stage of the cycle is elite. While M&A integration costs are dragging down GAAP margins temporarily, the core operational execution—especially in EMG—proves their decentralized growth model is working.
Key Themes
Explosive Order Growth Defies Macro Trends
AMETEK reported 28% order growth in Q2, accelerating from the 23% growth seen in Q1. This was explicitly driven by broad-based strength in semiconductor capital equipment, commercial aerospace, medtech, and defense. This sustained demand directly feeds the company's record backlog, ensuring robust top-line visibility into the second half of FY26.
EMG Margins Reach New Heights
The Electromechanical Group (EMG) is firing on all cylinders. Sales grew 17% YoY to $723.2 million, but more importantly, adjusted operating profit surged 32%. Core operating margins in this segment expanded by an incredible 290 basis points, proving that the division has fully emerged from the historical inventory destocking cycles and is realizing massive volume leverage on new production.
Reported Margins Diluted by M&A Spree
While management highlighted a 110-basis point 'core' operating margin expansion, this narrative ignores the structural drag of recent acquisitions. GAAP operating margin actually decelerated to 25.8% (down from 26.0% a year ago). The company noted a 50-basis point dilutive impact from recent acquisitions and foreign exchange, illustrating the near-term profitability penalty of their aggressive capital deployment strategy.
Heavy Reliance on Non-GAAP Adjustments
The gap between GAAP and non-GAAP earnings is widening significantly. In Q2, AMETEK added back $0.32 per share (roughly 15% of the adjusted $2.09 EPS) for non-cash amortization, integration costs, and one-time Indicor bridge financing fees. While stripping these out shows strong underlying performance, investors must monitor whether these 'one-time' integration costs become a permanent fixture of the M&A model.
Secular Infrastructure and Semiconductor Build-out
Management explicitly cited the 'global infrastructure build-out' as a primary catalyst for growth. The EIG segment's 14% growth is heavily supported by the resurgence in semiconductor capital equipment orders. The continued rollout of AI-driven data centers and fab reshoring acts as a multi-year secular tailwind that shields AMETEK from broader short-cycle industrial weakness.
Mission-Critical Technology Integration
AMETEK continues to lean into highly differentiated tech niches to protect pricing power. Through recent integration of FARO Technologies (3D metrology) and LKC Technologies (ophthalmic diagnostics), the company is pivoting heavily into hardware-software systems where switching costs are prohibitively high, supporting their stated 111% free cash flow conversion rate.
Other KPIs
Accelerating. Up 14% YoY, an acceleration from the 11% growth seen in Q1. This was fueled by intense orders growth in semiconductor and commercial aerospace markets. Core margins expanded by a healthy 40 basis points to 30.1%.
Accelerating. Up 35% YoY, completely outpacing the 15% revenue growth and 13.5% net income growth. Free cash flow conversion to net income landed at a robust 111%, demonstrating elite working capital management despite scaling the business.
Guidance
Accelerating vs prior expectations. Management raised the full-year guide from a previous midpoint of $8.04 to $8.25. This implies 10% to 12% YoY growth compared to FY25. The raise reflects the massive order intake and superior margin performance recorded in the first half.
Stable. The company expects total sales for the year to grow approximately 10% versus 2025. Given that Q1 grew 11% and Q2 grew 15%, this mathematically implies a deceleration in the back half of the year, likely due to tougher comps or deliberate conservatism.
Decelerating. The implied 10-11% YoY growth is a step down from the 17% YoY growth achieved in Q2. Sequentially, the $2.09 midpoint is flat compared to Q2's $2.09 result.
Decelerating. After posting 15% growth in Q2, guiding for high single digits (roughly 7-9%) in Q3 suggests that the explosive 28% order growth will take longer to convert to revenue, or management is baking in a wider margin of safety.
Key Questions
Order Conversion Disconnect
You achieved a staggering 28% order growth in Q2 following 23% in Q1. Yet, Q3 sales guidance calls for only 'high single digits' growth. Are extended supply chain lead times preventing you from shipping these orders, or is this guide purely conservative?
GAAP Margin Timeline
Core margins are expanding beautifully, but GAAP margins contracted 20 basis points YoY due to M&A dilution and integration costs. When do you expect the recent crop of acquisitions (FARO, First Aviation) to reach the corporate margin average and stop dragging down the GAAP print?
Organic vs Inorganic Transparency
Of the 15% total sales growth recorded in Q2, exactly how much was driven purely by organic volume and price versus the inorganic contribution from recent integrations?
Semiconductor Trajectory
You cited semiconductor capital equipment as a standout for order growth. Are you seeing this demand strictly from AI-related infrastructure (like advanced packaging), or is the broader, traditional memory and logic market also inflecting positively?